Shifting Paradigm: Clinical Benefit of Early Rhythm Control
Back to course
Video Transcription
0:00
All right, well, thank you very much for the opportunity to speak today. So a little bit of a timelague for you to look at my disclosures.
0:10
All right, so I'm Jim Freeman, I'm hailing from Yale. Thank you again for the opportunity to be here today. I'll be talking about the benefits of early AF rhythm control.
0:18
And actually judging by the answers to the questions, I've got some work to do. So this will be exciting and fun.
0:25
I always like to start this talk just by talking about the significance of atrial fibrillation. I know people are probably aware of this, but it's important to reiterate
0:33
that this is the most common cardiac arrhythmia. It impacts about 15 to 20% of Americans over the course of their lifetime. There's an increasing prevalence in all age groups.
0:42
Hospitalization with atrial fibrillation as a primary discharge diagnosis is increasing. And it worsens outcomes, including both mortality and stroke.
0:50
About a quarter of all strokes in the United States annually are from atrial fibrillation. And then of course it causes symptoms and decreases quality of life.
Video Summary
The speaker discusses the significance of atrial fibrillation (AF) and the benefits of early rhythm control. They highlight that AF is the most common cardiac arrhythmia, impacting a large number of Americans. Hospitalizations due to AF are increasing and it worsens outcomes such as mortality and stroke. The speaker refers to the East AF NATE-4 trial, which showed that early rhythm control with antiarrhythmic drugs improves cardiovascular outcomes, including a decrease in death and stroke, in patients with early AF. They also mention studies on catheter ablation which show a significant reduction in AF burden and improvements in quality of life. Finally, the speaker discusses the CABANA trial which compares catheter ablation with medical management and suggests potential benefits in terms of hard outcomes. They also mention the CASEL-AF study which shows that catheter ablation improves heart outcomes, especially in patients with systolic heart failure.
Keywords
atrial fibrillation
early rhythm control
cardiac arrhythmia
antiarrhythmic drugs
CABANA trial
Android App Download IOS App Download Powered By